Alveolar echinococcosis of the liver: A parasitic disease in search of a treatment
Open Access
- 1 September 1990
- journal article
- editorial
- Published by Wolters Kluwer Health in Hepatology
- Vol. 12 (3) , 617-618
- https://doi.org/10.1002/hep.1840120329
Abstract
The efficacy of albendazole (50 mg/kg/d), mebendazole (50 mg/kg/d) and praziquantel (500 mg/kg/d) against established intraperitoneal infections of Echinococcus multilocularis in gerbils was compared by monitoring parasite weight and making ultrastructural observations on treated and untreated material. Praziquantel was the most active protoscolicidal agent, reducing protoscolex viability to <2%, although it did not inhibit cyst growth. Albendazole was the most effective agent in reducing cyst growth and was, when compared with other regimes, significantly more effective than mebendazole (p < 0.05), praziquantel (p < 0.01) or untreated controls (p < 0.01).Keywords
This publication has 5 references indexed in Scilit:
- Comparison of the viability and developmental characteristics of Echinococcus multilocularis isolates from human patients in FranceInternational Journal for Parasitology, 1990
- Alveolar echinococcosis of the liverJournal of Hepatology, 1989
- In vitro culture of Echinococcus multilocularis: protoscolicidal action of praziquantel and albendazole sulphoxideTransactions of the Royal Society of Tropical Medicine and Hygiene, 1988
- Consequences of continuous mebendazole therapy in alveolar hydatid disease—with a summary of a ten-year clinical trialPathogens and Global Health, 1986
- Collagen immunotyping of the hepatic fibrosis in human alveolar echinococcosisZeitschrift Fur Parasitenkunde-Parasitology Research, 1986